CHICAGO & NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, will showcase its family of computer-aided detection (CAD) and advanced imaging solutions at the Radiological Society of North America (RSNA) Annual Meeting this week in Chicago, Ill. Specifically, iCAD will highlight the latest version of its magnetic resonance imaging (MRI) product suite which includes a new MRI-guided prostate biopsy prototype, as well as an integrated MR/TRUS-FUSION work-in-progress solution. In addition, iCAD’s VeraLook CT CAD technology will be demonstrated with Vital Images Vitrea workstation for the first time since the combined solution was made available earlier this year.
